Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

New Jersey Resources Support Entrepreneur David Fischell’s Mission to Create Life-Saving Medical Devices

Trenton, NJ, August 4, 2015 ― The New Jersey Economic Development Authority (EDA) continues its series highlighting how entrepreneurs and investors are helping to build New Jersey’s technology ecosystem

Serial entrepreneur Dr. David Fischell, of Fair Haven, has founded and led more than a dozen medical device companies to success in the last 20 years.

To Fischell, developing medical devices is a family affair.  David, along with his father Dr. Robert Fischell, a physicist, and his brother Dr. Tim Fischell, a cardiologist, started New Providence-based Svelte Medical Systems in 2007.

The company produces a cost-effective expandable coronary stent system featuring the smallest diameter in the industry.  This stent has led to a new standard of care in treating the buildup of plaque in the coronary arteries feeding blood to the heart, known as atherosclerosis.

Svelte’s legacy follows the Fischells’ work on stent design begun in late 1993, that ultimately led to David’s design of the Cordis CypherTM stent, the world’s first drug eluting stent sold by Johnson & Johnson (J&J) and implanted in more than five million patients.

David Fischell holds 140 issued US patents, and in total, the Fischell family has more than 250 patents to its name. Their medical device inventions run the gamut from implantable devices that detect and treat epileptic seizures to catheters used to cure high blood pressure.

“Serial entrepreneurs like Dr. Fischell enjoy the challenge of identifying unmet needs and finding ways to use technology to address those challenges,” EDA CEO Melissa Orsen said. “This fosters a spirit of innovation that fuels New Jersey’s technology ecosystem by creating jobs, and reinforcing the State’s image as a place for technology businesses to grow and thrive.”

Fischell currently serves as the CEO of Angel Medical Systems, a medical device company in Shrewsbury that he founded with his father and brother, in 2001.  Angel Medical is seeking Food and Drug Administration approval for its implantable GuardianTM System, designed to detect and alert patients to the onset of a heart attack, allowing them to seek immediate help.

Both Svelte Medical Systems and Angel Medical Systems have taken advantage of State resources including the Technology Business Tax Certificate Transfer (NOL) Program. Svelte Medical Systems also raised $4.8 million last year from David and Robert Fischell and other investors who were able to benefit from the State’sAngel Investor Tax Credit Program.

After completing a PhD in Applied Physics at Cornell University in 1979, Fischell moved to New Jersey and took a job at Bell Laboratories’ largest facility in Holmdel, where he spent his time performing and then directing research and development projects. He left Bell Laboratories in 1991 to focus on creating medical devices.

Like many New Jersey entrepreneurs, Fischell is active in several organizations that encourage collaboration within the entrepreneurial community. He is a member of the Institute of Electrical and Electronics Engineers, headquartered in Piscataway, whose core mission is to foster innovation and excellence. He’s also aFellow of the American Institute for Medical and Biological Engineering and a Trustee of Cornell University, his alma mater.

@NJEDATech spoke with Fischell about his experience growing companies in New Jersey:

For more information about resources available to support New Jersey’s technology industry, visit http://www.njeda.com/tls.